IRMD - NASDAQ
IRadimed Corporation
$94.48
+5.1%IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
At a Glance
Live SnapshotIRadimed Corporation Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Moderate conversion rate. Some gap between earnings and cash flow may warrant investigation into working capital or non-cash items.
CapEx Intensity
Moderate capital requirements typical of many stable businesses. Healthy balance between reinvestment and cash generation.
FCF Growth Trend
Flat FCF growth. Stable but not expanding—monitor for signs of business maturity or temporary headwinds.
Working Capital Impact
Moderate working capital outflow. Typical for growing businesses, but ensure it's supporting revenue growth, not inefficiency.
Cash Flow Quality Insight
Solid cash generation: Positive free cash flow with reasonable earnings quality provides financial flexibility for growth investments, debt reduction, or shareholder returns.
IRadimed Corporation Cash Flow Statement
IRMD • NASDAQ
| IRadimed Corporation Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||
22.5M | 19.2M | 17.2M | 12.8M | 9.3M | 1.4M | 9.6M | 6.3M | 499.8K | 7.2M | 7.5M | 2.1M | 1.9M | 966.1K | |
1.2M | 817.7K | 765.2K | 670.7K | 1.4M | 1.3M | 1.2M | 1.1M | 1.3M | 248.3K | 223.9K | 149.1K | 139K | 106.3K | |
0.0 | -697.7K | -1.2M | 57.1K | 523.6K | 389.9K | -596.8K | -144.4K | -150.7K | -570.9B | -16.1K | -167.3K | 0.0 | 0.0 | |
2.9M | 2.5M | 2.2M | 1.4M | 1.5M | 4M | 1.9M | 1.8M | 2.5M | 1.8M | 1.2M | 724.1K | 271.9K | 173.2K | |
2.7M | -3K | 402.3K | 148.7K | 119K | -70.1K | 68.7K | 155.7K | 425K | 570.9B | -1.6M | 229.4K | -651.5K | -430.0 | |
(0.0) | (6.5M) | (5.4M) | (1.7M) | (970K) | (0.0) | (12K) | (1.4M) | (1.2M) | (3.4M) | (2.7M) | (1.2M) | (1.4M) | (0.0) | |
-4.3M | 3.7M | -5.9M | -5.1M | -1.6M | -1.2M | -2M | -1.8M | -1.1M | 514.3K | 290.3K | -399.8K | -873.5K | 264K | |
24.9M | 25.6M | 13.5M | 10M | 11.3M | 5.8M | 10.2M | 7.4M | 3.4M | 9.4M | 7.6M | 2.6M | 1.5M | 1.5M | |
INVESTING ACTIVITIES | ||||||||||||||
-7.8M | -8M | -7.4M | -823K | -482.3K | -636.7K | -368.3K | -264.7K | -824.8K | -1.5M | -314.8K | -606.3K | -191.8K | -161.6K | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (36.4K) | (49.2K) | (743.5K) | (0.0) | (22.3K) | (0.0) | (0.0) | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -1.1M | -2.7M | -5M | (0.0) | -8M | -5K | -4.7K | |
0.0 | 0.0 | 0.0 | 500K | 1.4M | 883.7K | 3.7M | 2.9M | 2.5M | 4.6M | 253.4K | 255.1K | 0.0 | 0.0 | |
-656K | -811.8K | -566.7K | -1.1M | -259.4K | 0.0 | -117.5K | -36.4K | -49.2K | -743.5K | 237.3K | -22.3K | -33.6K | -53.3K | |
-8.4M | -8.8M | -8M | -1.4M | (648.2K) | (247K) | (3.2M) | (1.5M) | -1M | -1.9M | -61.5K | -8.3M | -196.7K | -166.3K | |
FINANCING ACTIVITIES | ||||||||||||||
0.0 | 29.6K | 0.0 | 0.0 | 0.0 | 1.7M | 0.0 | 0.0 | -1.8M | -10M | 0.0 | 14.5M | 0.0 | 0.0 | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -6.3K | 0.0 | 0.0 | |
-15M | -13.7M | -13.2M | -12.6M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -309.6K | -1.8M | -10M | (0.0) | (0.0) | (0.0) | (0.0) | |
-2.6M | -688.2K | -433.6K | -147.3K | 24.4K | -1.2M | 2M | 929.9K | -81.8K | 850.7K | 2.3M | -1.8M | -513.4K | -238.5K | |
-17.6M | -14.3M | -13.7M | -12.7M | 24.4K | 522.5K | 2M | 929.9K | -1.9M | -9.1M | 2.3M | 12.7M | -513.4K | -238.5K | |
CASH FLOW SUMMARY | ||||||||||||||
-1.1M | 2.5M | -8.2M | -4M | 11.9M | 6.6M | 15.5M | 9.8M | 492.1K | -1.7M | 9.9M | 7M | 764.3K | 1.1M | |
52.2M | 49.8M | 58M | 62M | 50.1M | 43.5M | 28M | 18.2M | 17.7M | 19.4M | 9.5M | 2.5M | 1.7M | 593K | |
51.2M | 52.2M | 49.8M | 58M | 62M | 50.1M | 43.5M | 28M | 18.2M | 17.7M | 19.4M | 9.5M | 2.5M | 1.7M | |
17.2M | 17.6M | 5.5M | 8.2M | 10.5M | 5.2M | 9.7M | 7.1M | 2.6M | 7.9M | 7.3M | 2M | 1.3M | 1.3M |
SEC Filings
IRMD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 01, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 01, 2026 | May 01, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 30, 2026 | June 23, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 06, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 10, 2026 | February 10, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 08, 2025 | December 05, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 03, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 03, 2025 | November 03, 2025 | 2025 | |
10-K/A 10-K/A 2024 FY (Amended) FY | September 03, 2025 | December 31, 2024 | 2024 | |
8-K 8-K 2025 N/A | September 02, 2025 | August 27, 2025 | 2025 |
Related Guides
Continue your IRMD research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.